ABOS

Quote

Short

News

Articles

Message Board

Acumen Pharmaceuticals Inc. (NASDAQ : ABOS ) News

News Releases

ABOS News Releases

July 07, 2026 07:30:00 am

GlobeNewswire

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery(TM) (EBD(TM)) Technology and Early Alzheimer's Disease Insights at the Alzheimer's Association International Conference (AAIC®) 2026

June 17, 2026 12:30:00 pm

Business Wire

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

June 16, 2026 07:30:00 am

GlobeNewswire

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery(TM) (EBD(TM)) Development Candidates for the Treatment of Alzheimer's Disease

May 20, 2026 07:45:03 am

SeekingAlpha

Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet

May 14, 2026 02:20:43 pm

SeekingAlpha

Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 12, 2026 12:40:49 pm

Motley Fool

Acumen (ABOS) Q1 2026 Earnings Transcript

May 12, 2026 11:31:52 am

SeekingAlpha

Acumen expects ALTITUDE-AD top-line results in late 2026 while targeting a mid-2027 IND for 2 EBD candidates

May 12, 2026 11:30:49 am

SeekingAlpha

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript

May 12, 2026 07:14:07 am

SeekingAlpha

Acumen Pharmaceuticals GAAP EPS of -$0.33 beats by $0.03

May 12, 2026 07:00:00 am

GlobeNewswire

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account